Clinical Trial Update: Use of Low-dose Zolpidem in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update on low-dose zolpidem in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Zolpidem (zolpidem)

Snippet

Sponsor: Aston University | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED